SIMULTANIOUS DETERMINATION OF ANTIRETROVIRAL DRUGS EMTRICITABINE AND TENOFOVIR DESOPROXIL FUMERATE BY A STABILITY INDICATING RP-HPLC METHOD

  • Valli Purnima B. Acharya Nagarjuna University
  • Vijaya Bhaskara Reddy T. Acharya Nagarjuna University
  • Suneetha Y. Acharya Nagarjuna University
  • Ramachandran D. Dr. Samuel George Institute of Pharmaceutical Science, Markapur, Andhra Pradesh, India

Abstract

Objective: The objective of the present investigation is to develop a stability indicating RP-HPLC method for the simultaneous estimation of Emtricitabine (EMT) and Tenofovir Desoproxil Fumerate (TDF) in pure and tablet dosage forms.

Methods: Waters (Alliance) HPLC 2695 series systems equipped with UV detector was adopted for the chromatographic analysis. The separation was achieved by injecting 20 µl of working standard solution of concentration 60 µg/ml of EMT and 90 µg/ml of TDF into the Inertsil ODS C-18 (250 mm x 4.6 mm, 5 µm) column maintained at ambient temperature, elution was carried out by 0.1% triflouro acetic acid (TFA) buffer and methanol in the ratio 39:61 (v/v) as mobile phase at a flow rate of 1.2 ml/min, and the detection at a wavelength at 261 nm.

Results: The system suitability parameters such as tailing factor (1.41&1.43), theoretical plates (2470&3059), resolution (4.21) and chromatographic parameters like retention time (2.387&3.293 min), peak area (147228&250057), peak height (20731&26892) of EMT and TDF were evaluated. The developed method was validated in terms precision (for system precision and method precision, the %RSD was found to be 0.4637&0.3176 and 0.3502&0.2789 for EMT and TDF respectively), accuracy (percent of recovery was found to be 99.21-100.16&100.78-101.16), linearity (20-100µg/ml&30-150 µg/ml), limit of detection (0.48&0.56 µg/ml), limit of quantitation (1.64&1.89 µg/ml) for EMT and TDF respectively. The developed method was applied for the determination of assay of Truvada and the percent of assay was found to be in the range of 100.74-101.56.

Conclusion: A simple, rapid and economic RP-HPLC method for simultaneous determination of EMT and TDF in bulk and formulations was developed and validated. The developed method was found to be precise, accurate, linear, robust and rugged. This method was successfully applied for the assay of Truvada; hence it can be adopted for the determination of quality in any quality control laboratory.

 

Keywords: RP-HPLC method, Truvada, Validation, Stability, Emtricitabine, Tenofovir Desoproxil Fumerate

Downloads

Download data is not yet available.

References

1. Anandakumar K, Kannan K, Vetrichelvan T. Development and validation of emtricitabine and tenofovir disoproxil fumerate in pure and in fixed dose combination by UV spectrophotometry. Dig J Nanomater Biostructures 2011;6:1085–90.
2. Patel S, Baghel US, Rajesh P, Prabhakar D, Engla G, Nagar PN. Spectrophotometric method development tenofovir disoproxil fumerate and emtricitabine in bulk drug and tablet dosage form. Int J Pharm Clin Res 2009;1:28–30.
3. Choudhari VP, Ingale KD, Barhate A, Kale AN, Bobade CD, Kuchekar BS. Development and validation of Simultaneous and Isoabsorptive UV-Spectrophotometric methods for tenofovir and emtricitabine in pharmaceutical formulations. J Pharm Res 2010;9:11–3.
4. Ghorpade SA, Sali MS, Kategaonkar AH, Patel DM, Choudhari VP, Kuchekar BS. Simultaneous determination of emtricitabine and tenofovir by area under curve and dual wavelength spectrophotometric method. J Chil Chem Soc 2010;54:331–3.
5. Vishnu PC, Snehal Ingale, Sacchidanand RG, Dipali DT, Vikram GM, Archana Ambekar. Spectrophotometric simultaneous determination of tenofovir disoproxil fumerate and emtricitabine in combined tablet dosage form by ratio derivative, first order derivative and absorbance corrected methods and its application to dissolution study. J Pharmacol Methods 2011;2:47–52.
6. Ahindita P, Aurobinda KM, Amit GS, Dannana K, Swapna M, Sudam CSI. Development and validation of spectrophotometric methods for determination of emtricitabine and tenofovir disoproxil Fumerate in bulk and tablet dosage form. Int J PharmTech Res 2010;3:1874-82.
7. Ghorpade SA, Sali, Kategaonkar AH, Patel DM, Choudhari VP, Kuchekar BS. Simultaneous determination of emtricitabine and tenofovir by area under curve and dual wavelength spectrophotometric method. J Chil Chem Soc 2010;55:115–7.
8. Choudhari VP, Ingale S, Gite SR, Tajane DD, Modak VG, Ambekar A. Spectrophotometric simultaneous determination of tenofovir disoproxil Fumerate and emtricitabine in combined tablet dosage form by ratio derivative, first order derivative and absorbance corrected methods and its application to dissolution study. Pharm Methods 2011;1:47–52.
9. Karunakaran A, Kamarajan K, Thangarasu V. A validated RP-HPLC method for simultaneous estimation of emtricitabine and tenofovir disoproxil Fumerate in pure and in tablet dosage form. Pharm Sin 2010;1:52–60.
10. Sharma R, Gupta P. A validated RP-HPLC method for simultaneous estimation of emtricitabine and tenofovir disoproxil Fumerate in a tablet dosage form. Eurasian J Anal Chem 2009;4:276–84.
11. Pranitha D, Vanitha C, Francies P. Simultaneous estimation of emtricitabine, tenofovir disoproxil Fumerate, and rilpivirine in bulk form by RP-HPLC method. J Pharm Res 2010;5:4600-2.
12. Raju NA, Begum S. Simultaneous RP-HPLC method for the estimation of the emtricitabine, tenofovir disoproxil Fumerate and efavirenz in tablet dosage forms. Res J Pharm Technol 2008;1:522-5.
13. Prashant SD, Roshan Borkar, Nalini Shastri, Surendranath KV. A validated stability-indicating RP-HPLC method for the simultaneous determination of tenofovir, emtricitabine, and a efavirenz and statistical approach to determine the effect of variables. ISRN Chromatogr 2013. doi.org/10.1155/2013/878295. [Article in Press]
14. Rezk NL, Crutchley RD, Kashuba AD. Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction. J Chromatogr B 2005;822:201–8.
15. Nirogi R, Bhyrapuneni G, Kandikere V, Mudigonda K, Komarneni P, Aleti R, et al. Simultaneous quantification of a non-nucleoside reverse transcriptase inhibitor efavirenz, a nucleoside reverse transcriptase inhibitor emtricitabine and a nucleotide reverse transcriptase inhibitor tenofovir in plasma by liquid chromatography positive ion electrospray tandem mass spectrometry. J Biomed Chromatogr 2009;23:371–81.
16. Gomes NA, Vaidya VV, Pudage A, Joshi SS, Parekh SA. Liquid chromatography-tandem mass spectrometry method for simultaneous determination of tenofovir and emtricitabine in human plasma and its application to a bioequivalence study. J Pharm Biomed Anal 2008;48:918–26.
17. Delahunty T, Bushman L, Robbins B, Fletcher CV. The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards. J Chromatogr B 2009;877:1907–14.
18. Avolio AD, Sciandra M, Siccardi M. A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients. J Chromatogr Sci 2008;46:524–8.
19. Yadav M, Singhal P, Goswami S, Pande UC, Sanyal M, Shrivastav PS. Selective determination of antiretroviral agents tenofovir, emtricitabine, and lamivudine in human plasma by a LC-MS-MS method for a bioequivalence study in healthy Indian subjects. J Chromatogr Sci 2010;48:704-13.
20. Joshi M, Nikalje AP, Shahed M, Dehghan M. HPTLC method for the simultaneous estimation of emtricitabine and tenofovir in tablet dosage form. Indian J Pharm Sci 2009;71:95–7.
21. Kavitha KY, Geetha G, Hariprasad R, Venkatnarayanan R, Kaviarasu M. Development and validation of RP-UPLC analytical method for simultaneous estimation of the emtricitabine, tenofovir disoproxil Fumerate and rilpivirine and its pharmaceutical dosageform. Int Res J Pharm 2013;4:150–5.
22. Nagaraju PT, Channabasavaraj KP, Shantha Kumar PT. Development and validation of spectrophotometric method for estimation of emtricitabine in tablet dosage form. Int J ChemTech Res 2011;3:23–8.
23. Droste JAH, Aarnoutse RE, Burger DM. Determination of emtricitabine in human plasma using HPLC with fluorometric detection. J Liq Chromatogr Relat Technol 2007;30:2769–78.
24. Ashenafi D, Verbeek A, Hoogmartens J, Adams E. Development and validation of an LC method for the determination of emtricitabine and related compounds in the drug substance. J Sep Sci 2009;32:1823–30.
25. Seshachalam U, Haribabu B, Chandrasekhar KB. Development and validation of a stability-indicating liquid chromatographic method for determination of emtricitabine and related impurities in drug substance. J Sep Sci 2007;30:999–04.
26. Pendela M, Mamade DA, Hoogmartens J, Van Schepdael A, Adams E. Characterization of emtricitabine related substances by liquid chromatography coupled to an ion trap mass spectrometer. Talanta 2010;82:125–8.
27. Atul HB, Charashila Sajai JS. Application of UV-spectrophotometric methods for estimation of tenofovir disoproxil fumerate in tablets. Pak J Pharm Sci 2009;22:27–9.
28. Pratap Reddy J, Chakravarthy IE. New spectrophotometric determination of tenofovir disoproxil fumeratein bulk and pharmaceutical dosage form. IOSR J Appl Chem 2012;1:29–33.
29. Rani TS, Sujatha K, Chitra K. Spectrophotometric methods for estimation of tenofovir disoproxil fumerate in tablet. Res Rev J Pharm Anal 2012;1:9–12.
30. Onah JO, Ajima U. Spectrophotometric determination of tenofovir disoproxil Fumerate after complexation with ammonium molybdate and picric acid. Int J Drug Dev Res 2011;3:199–204.
31. Kandagal PB, Manjunatha DH, Seetharamappa J, Kalanur SS. RP-HPLC method for the determination of tenofovir in pharmaceutical formulations and spiked human plasma. Anal Lett 2008;41:561–70.
32. Jullien V, Tréluyer JM, Pons G, Rey E. Determination of tenofovir in human plasma by high-performance liquid chromatography with spectrofluorimetric detection. J Chromatogr B 2003;785:377–81.
33. Sparidans RW, Crommentuyn KML, Schellens JHM, Beijnen JH. Liquid chromatographic assay for the antiviral nucleotide analogue tenofovir in plasma using derivatization with chloroacetaldehyde. J Chromatogr B: Anal Technol Biomed Life Sci 2003;791:227–33.
34. Bhavsar S, Patel BN, Patel CN. RP-HPLC method for simultaneous estimation of tenofovir disoproxil fumerate, lamivudine, and efavirenz in combined tablet dosage form. Pharm Methods 2012;3:73–8.
35. Barkil ME, Gagnieu M, Guitton J. Relevance of a combined UV and single mass spectrometry detection for the determination of tenofovir in human plasma by HPLC in therapeutic drug monitoring. J Chromatogr B 2007;54:192–7.
36. Sentenac S, Fernandez C, Thuillier A, Lechat P, Aymard G. Sensitive determination of tenofovir in human plasma samples using reversed-phase liquid chromatography. J Chromatogr B 2003;793:317–24.
37. Delahunty T, Bushman L, Fletcher CV. Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS. J Chromatogr B 2006;830:6–12.
Statistics
663 Views | 862 Downloads
How to Cite
B., V. P., V. B. Reddy T., S. Y., and R. D. “SIMULTANIOUS DETERMINATION OF ANTIRETROVIRAL DRUGS EMTRICITABINE AND TENOFOVIR DESOPROXIL FUMERATE BY A STABILITY INDICATING RP-HPLC METHOD”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 7, no. 9, July 2015, pp. 390-8, https://innovareacademics.in/journals/index.php/ijpps/article/view/6575.
Section
Original Article(s)